Peter Caravan Selected Research

1,8- (2,6- pyridinedimethylene)- 1,4,8,11- tetraazacyclotetradecane- 2,4- diacetic acid

2/2014

Pycup--a bifunctional, cage-like ligand for (64)Cu radiolabeling.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Peter Caravan Research Topics

Disease

34	Fibrosis (Cirrhosis) 10/2023 - 01/2007
19	Thrombosis (Thrombus) 01/2022 - 01/2008
14	Neoplasms (Cancer) 05/2024 - 01/2008
11	Liver Cirrhosis (Hepatic Cirrhosis) 01/2023 - 09/2012
9	Inflammation (Inflammations) 10/2023 - 04/2009
7	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2023 - 12/2013
7	Liver Diseases (Liver Disease) 01/2023 - 04/2014
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2016
4	Idiopathic Pulmonary Fibrosis 11/2023 - 01/2019
4	Atherosclerotic Plaque (Atheroma) 01/2022 - 04/2009
3	Adenocarcinoma 05/2024 - 01/2017
3	Pancreatic Neoplasms (Pancreatic Cancer) 05/2024 - 01/2018
3	Cicatrix (Scar) 07/2023 - 06/2008
3	Infarction (Infarctions) 07/2023 - 11/2011
3	Myocardial Infarction 07/2023 - 06/2008
3	Hepatocellular Carcinoma (Hepatoma) 01/2023 - 04/2014
3	Chronic Renal Insufficiency 01/2023 - 10/2014
3	Non-alcoholic Fatty Liver Disease 01/2023 - 05/2018
3	Atherosclerosis 01/2022 - 04/2009
2	Fatty Liver 10/2023 - 05/2018
2	Disease Progression 10/2023 - 01/2021
2	Lung Diseases (Lung Disease) 10/2023 - 01/2022
2	Lung Injury 01/2022 - 01/2020
2	Cardiovascular Diseases (Cardiovascular Disease) 10/2020 - 03/2010
2	Breast Neoplasms (Breast Cancer) 11/2019 - 10/2012
2	Necrosis 11/2011 - 03/2010
2	Nephrogenic Fibrosing Dermopathy 12/2009 - 12/2009
1	Post-Acute COVID-19 Syndrome 01/2024
1	Chemical and Drug Induced Liver Injury 10/2023
1	Ischemia 01/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Renal Insufficiency (Renal Failure) 01/2023
1	Hyperphosphatemia 01/2023
1	Cholestasis 09/2022
1	Alzheimer Disease (Alzheimer's Disease) 01/2022
1	Multiple Sclerosis 01/2022
1	Rupture 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2022

Drug/Important Bio-Agent (IBA)

24	CollagenIBA 11/2023 - 01/2007
21	Contrast MediaIBA 01/2023 - 01/2007
17	FibrinIBA 01/2022 - 01/2008
16	GadoliniumIBA 01/2023 - 05/2008
13	Collagen Type I (Type I Collagen)IBA 01/2023 - 09/2012
10	Peptides (Polypeptides)IBA 11/2023 - 03/2012
7	allysineIBA 05/2024 - 01/2017
7	Hydroxyproline (4 Hydroxyproline)IBA 10/2023 - 09/2012
6	Proteins (Proteins, Gene)FDA Link 01/2024 - 05/2008
6	Biomarkers (Surrogate Marker)IBA 10/2023 - 03/2010
6	EP-2104RIBA 01/2020 - 05/2008
5	Bleomycin (Blenoxane)FDA LinkGeneric 11/2023 - 12/2013
5	Carbon Tetrachloride (Tetrachloromethane)IBA 01/2023 - 09/2012
5	Gadolinium DTPA (Magnevist)FDA Link 10/2012 - 06/2008
4	Choline (Choline Chloride)IBA 10/2023 - 01/2021
4	Amino Acids FDA Link 10/2023 - 01/2021
4	Diethylnitrosamine (N-Nitrosodiethylamine)IBA 01/2020 - 09/2012
3	folfirinoxIBA 05/2024 - 01/2018
3	AldehydesIBA 10/2023 - 01/2022
3	ManganeseIBA 01/2023 - 10/2018
3	streptococcal polysaccharide type III group BIBA 01/2023 - 01/2018
3	Peroxidase (Myeloperoxidase)IBA 01/2022 - 01/2018
2	ferric oxide (iron oxide)IBA 01/2023 - 11/2020
2	Oxidoreductases (Dehydrogenase)IBA 01/2023 - 01/2022
2	gadolinium ethoxybenzyl DTPA FDA Link 01/2023 - 11/2019
2	Phosphates (Orthophosphate)IBA 01/2023 - 04/2016
2	Molecular Probes (Molecular Probe)IBA 09/2022 - 01/2019
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 01/2022 - 10/2019
2	Extracellular Matrix ProteinsIBA 01/2022 - 09/2012
2	Radioisotopes (Radionuclides)IBA 01/2021 - 01/2020
2	Messenger RNA (mRNA)IBA 01/2021 - 07/2018
2	ErbB Receptors (EGF Receptor)IBA 01/2021 - 04/2014
2	EP3533IBA 01/2021 - 01/2019
2	gadolinium 1,4,7,10- tetraazacyclododecane- N,N',N'',N'''- tetraacetateIBA 01/2020 - 11/2019
2	EDP-305IBA 01/2019 - 07/2018
2	IntegrinsIBA 01/2018 - 05/2017
2	gadofosveset trisodium (MS 325)FDA Link 01/2018 - 05/2010
2	Liposomes (Liposome)IBA 01/2017 - 01/2016
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2017 - 01/2016
2	ferric chlorideIBA 10/2015 - 07/2015
1	N-acetyltalosaminuronic acid (NAT)IBA 05/2024
1	Acetaminophen (Paracetamol)FDA LinkGeneric 10/2023
1	deoxypyridinolineIBA 07/2023
1	pyridinolineIBA 07/2023
1	EnzymesIBA 01/2023
1	NAD (NADH)IBA 01/2023
1	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2023
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2023
1	PeroxidasinIBA 01/2022
1	5'- O- (9- phenylxanthen- 9- yl)- 2'- deoxynebularineIBA 01/2022
1	CholesterolIBA 01/2022
1	MethemoglobinIBA 01/2022
1	Interleukin-6 (Interleukin 6)IBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2022
1	Versicans (Versican)IBA 01/2022

Therapy/Procedure

17	Therapeutics 10/2023 - 03/2010
4	Drug Therapy (Chemotherapy) 05/2024 - 01/2017
2	Neoadjuvant Therapy 05/2024 - 01/2020
2	Ligation 09/2015 - 04/2014
1	Intraperitoneal Injections 10/2023
1	Intravenous Injections 01/2023
1	Carotid Endarterectomy 01/2022